Pfizer Says Long-Awaited Lyme Vaccine Was Effective in Study

2026-03-23 - 11:20

(Bloomberg) — Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well it works on a large scale. Read More